Reaction

Glossitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,510 reports · 97 co-occurring drugs

As of the last recalculation, Glossitis appears in 3,510 FAERS reports alongside 97 co-occurring drug terms. The strongest observed disproportionality signal is CABOZANTINIB (PRR 24.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Cabozantinib	187	24.3	24.4
Buprenorphine Hydrochloride, Naloxone Hydrochloride	52	13.0	13.0
Theophylline Anhydrous	25	12.0	12.1
Theophylline	23	11.9	12.0
Sunitinib Malate	74	11.4	11.4
Axitinib	33	10.1	10.1
Nicotine Polacrilex	64	10.1	10.1
Sorafenib	32	9.2	9.2
Asenapine Maleate	13	8.9	8.9
Regorafenib	17	8.7	8.7
Bisacodyl Suppositories	18	8.3	8.3
Biscodyl	18	8.2	8.2
Bisacodyl	19	8.0	8.1
Mercaptopurine	23	7.9	7.9
Felodipine Extended-Release Tablets	15	7.8	7.8
Felodipine	15	7.8	7.8
Panitumumab	20	7.6	7.6
Tiotropium Bromide Inhalation Spray	14	7.4	7.4
Chlorhexidine Gluconate	11	7.2	7.2
Nystatin Ointment	28	6.4	6.4
Nystatin Cream	28	6.4	6.4
Clotrimazole	13	6.3	6.3
Quinine	9	6.2	6.2
Drs. Clotrimazole	12	6.2	6.2
Family Wellness Clotrimazole	12	6.2	6.2
Clotrimazole Topical	12	6.2	6.2
Nystatin	28	6.1	6.1
Linezolid	29	5.8	5.8
Esomeprazole Magnesium Capsule, Delayed Release	14	5.7	5.7
Esomeprazole Magnesium Delayed Release Capsules	14	5.7	5.7
Esomeprazole Magnesium Dihydrate	14	5.7	5.7
Lubiprostone	9	5.7	5.7
Pazopanib Hydrochloride	25	5.5	5.5
Lenvatinib	30	5.5	5.5
Dicyclomine Hydrochloride	13	5.4	5.4
Sennosides 8.6 Mg Tablets	19	5.4	5.4
Senna	19	5.4	5.4
Brivaracetam	8	5.3	5.3
Clarithromycin	30	5.2	5.2
Lithium	22	5.2	5.2
Lithium Bromatum	22	5.2	5.2
Ribociclib	27	5.1	5.1
Candesartan	30	5.0	5.0
Senna Leaf	19	4.9	4.9
Mometasone Furoate	34	4.9	4.9
Budesonide And Formoterol Fumarate Dihydrate	77	4.8	4.8
Fexofenadine	13	4.7	4.7
Gefitinib	7	4.6	4.6
Amikacin	13	4.5	4.5
Loratadine And Pseudoephedrine Sulfate	6	4.5	4.5
Nicotine	30	4.4	4.4
Fluticasone Furoate	9	4.4	4.4
Fulvestrant	24	4.3	4.3
Tiotropium Bromide	97	4.3	4.3
Sennosides	21	4.2	4.2
Anastrozole Tablets	15	4.2	4.2
Armodafinil	14	3.9	4.0
Cetirizine Hydrochloride Allergy	19	3.7	3.7
Cetirizine Hydrochloride Tablets	19	3.7	3.7
Montelukast	52	3.7	3.7
Umeclidinium Bromide And Vilanterol Trifenatate	10	3.6	3.6
Levocetirizine Dihydrochloride	14	3.5	3.5
Peginterferon Alfa-2A	31	3.4	3.4
Ranolazine	6	3.4	3.4
Budesonide, Glycopyrrolate, And Formoterol Fumarate	6	3.4	3.4
Miconazole Nitrate	5	3.4	3.4
Hydroxyurea	12	3.4	3.4
Fluticasone Propionate And Salmeterol	23	3.3	3.3
Everolimus	28	3.3	3.3
Bimekizumab	11	3.1	3.1
Nivolumab	49	3.0	3.0
Niraparib	11	2.9	2.9
Pitavastatin Calcium	5	2.9	2.9
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	20	2.9	2.9
Rucaparib	4	2.7	2.7
Bosutinib	4	2.6	2.6
Ribavirin	28	2.6	2.6
Tafamidis	5	2.5	2.5
Pembrolizumab	43	2.4	2.4
Irinotecan Hydrochloride	5	2.3	2.3
Mometasone Furoate And Formoterol Fumarate Dihydrate	6	2.3	2.3
Vortioxetine	6	2.1	2.1
Fremanezumab-Vfrm	4	2.1	2.1
Palbociclib	33	2.1	2.1
Alpelisib	3	2.0	2.0
Nirmatrelvir And Ritonavir	18	2.0	2.0
Varenicline Tartrate	26	1.9	1.9
Cetuximab	10	1.9	1.9
Treprostinil	36	1.7	1.7
Trifluridine And Tipiracil	3	1.7	1.7
Benralizumab	5	1.5	1.5
Abaloparatide	7	1.4	1.4
Orlistat	6	1.4	1.4
Glycerin, Lidocaine	3	1.3	1.3
Docosanol	3	1.2	1.2
Ixekizumab	7	1.1	1.1
Osimertinib	6	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.